Will Xanax help Restless Leg Syndrome?
It is very unlikely to help, and the reason is worth understanding before you ask for a script. Restless Legs Syndrome is an urge to move, not a failure to feel sleepy. A sedative makes you sleepier. It does not quieten the urge, so you end up heavy-eyed with legs that still will not sit still.
That gap between drowsy and settled is the specific misery people describe after a sedative night. You are too foggy to read and too restless to lie down, so you walk the hallway feeling drugged and wired together. It is the same pattern readers report with sedating antihistamines, covered in our guide to Benadryl and Restless Legs.
Nobody is calling you foolish for trying. The logic is sound on the surface: the legs stop you sleeping, so knock yourself out. It just does not work on this problem.
Can you get Xanax for Restless Legs in Australia?
Finding out now beats finding out in the consulting room, and in Australia the answer is mostly no. Alprazolam became a Schedule 8 controlled drug here on 1 February 2014, which means a prescriber now needs a permit before writing it at all.
That change matters more than it sounds. The Victorian Department of Health prescribing guidance states that support from a psychiatrist will generally be required, because alprazolam is approved only for short-term anxiety or panic disorder.
Expect a no, and it is not your GP being difficult. Restless Legs Syndrome is not on that approved list, so asking for alprazolam for leg symptoms asks your GP to prescribe outside it, under a system built to keep use short and supervised.
If you are already taking alprazolam or another benzodiazepine for anxiety, do not stop it on your own. Benzodiazepine withdrawal can be genuinely unpleasant and occasionally dangerous, and it needs a planned taper with your GP. Nothing in this article is a reason to skip tonight’s dose.
What does the 2024 guideline say about clonazepam for Restless Legs?
The one benzodiazepine that has been formally assessed got a thumbs down, which settles a question a lot of long-term patients have been carrying. The 2024 American Academy of Sleep Medicine guideline (Winkelman et al., Journal of Clinical Sleep Medicine) conditionally recommends against clonazepam for Restless Legs Syndrome in adults.
The reason given is worth hearing in full. There was little evidence supporting its efficacy, and what evidence existed was outweighed by the risks of sedation and cognitive impairment.
Seeing where your medicine actually sits makes the next GP conversation much easier to have.
| Medicine or approach | 2024 AASM guideline position | What that means for you |
|---|---|---|
| Gabapentin, gabapentin enacarbil, pregabalin | Strong recommendation for | First choice when medication is warranted |
| Intravenous ferric carboxymaltose | Strong recommendation for | For adults with low iron stores |
| Ferrous sulfate (iron tablets) | Conditional recommendation for | Sits behind an iron blood test |
| Oxycodone ER and other opioids | Conditional recommendation for | Reserved for severe, refractory cases |
| Peroneal nerve stimulation | Conditional recommendation for | Prescription device, specialist access |
| Clonazepam | Conditional recommendation against | Little efficacy evidence, sedation and cognitive risks |
| Ropinirole, pramipexole, rotigotine, levodopa | Conditional recommendation against | Routine ongoing use discouraged, augmentation risk |
| Alprazolam (Xanax) and other benzodiazepines | Not assessed | No recommendation either way, no trial base |
If you are wondering whether you missed a line about Xanax, you did not. Alprazolam is not in the guideline at all, because there was nothing substantial to review.
The wider benzodiazepine picture is thinner still, and knowing that saves you wondering whether you missed something. Carlos and colleagues (2017), writing in the Cochrane Database of Systematic Reviews, set out to assess benzodiazepines for Restless Legs Syndrome and found that no randomised trials met their inclusion criteria.
Their conclusion was that there is no good data to support or refute the use of benzodiazepines for Restless Legs symptoms. Decades of prescribing, zero usable trials.
Are Restless Legs and anxiety connected?
If you feel anxious about going to bed, that is a rational response to your own history, not a separate illness you have developed. Lying awake with legs you cannot still, night after night, is a reliable way to build dread about bedtime.
That order of events matters, because the anxiety is often downstream of the Restless Legs rather than the cause of it. It changes what you treat first.
You will find confident claims in both directions online, and both are overselling it. Studies report an overlap between Restless Legs Syndrome and anxiety, but they disagree on its size and direction, so there is no clean number worth quoting at you.
There is one connection here that could change your nights, and it gets missed constantly. The 2024 American Academy of Sleep Medicine guideline names serotonergic medicines as an exacerbating factor to address before Restless Legs treatment begins. That is the class most antidepressants belong to. The same list includes antihistaminergic and antidopaminergic medicines, alcohol, caffeine and untreated sleep apnoea.
So if you take an antidepressant and your legs have got worse, those two facts may be related. Never stop an antidepressant on your own. Our guide to Restless Legs medication side effects covers what else to flag at that appointment.
What actually calms Restless Legs at night?
Walking in with a plan gets you further than walking in with a request for Xanax. These five steps are the order the 2024 American Academy of Sleep Medicine guideline and the published trial evidence support, and the first two are usually the ones that move the needle.
- Keep taking what you are prescribed. Any change to a benzodiazepine or an antidepressant is a planned conversation with your GP, never a decision made at 2am.
- Audit everything else you take. Sedating antihistamines, anti-nausea medicines and some antipsychotics are on the guideline’s list of aggravators. A pharmacist will go through your cupboard with you for free.
- Get your ferritin tested. Low iron stores are among the best-established aggravators of Restless Legs Syndrome, and it is one blood test. Our guide to iron, ferritin and Restless Legs covers what to ask for.
- Ask about the gabapentinoids. These now carry the guideline’s strong recommendation, ahead of the older dopamine drugs. Our comparison of gabapentin and ropinirole explains what changed and why.
- Try a drug-free option for the nights themselves. Targeted overnight compression has published trial evidence, nothing to swallow, and no interaction with your other medicines. The evidence for compression sets out the trials in detail.
That last option keeps appearing for one unglamorous reason: it is the only item on the list that cannot build tolerance or make your symptoms worse over years. Our full guide to drug-free Restless Legs treatment compares the options side by side.
What the research actually shows
Numbers settle arguments that reassurance cannot, so here is what the published work actually says. The short version: no trials support benzodiazepines for Restless Legs, the one benzodiazepine the 2024 guideline assessed is recommended against, and the controlled evidence that does exist sits with compression.
On benzodiazepines, the evidence base is empty. Carlos and colleagues (2017), in the Cochrane Database of Systematic Reviews, found no randomised clinical trials meeting inclusion criteria and concluded that the effectiveness of benzodiazepines for Restless Legs Syndrome is currently unknown.
On clonazepam specifically, the guideline recommends against it. Winkelman and colleagues (2024), in the Journal of Clinical Sleep Medicine, place clonazepam among the conditional recommendations against, citing little efficacy evidence outweighed by sedation and cognitive impairment risk.
On compression, there is controlled evidence. Lettieri and Eliasson (2009), in Chest, ran a randomised, double-blinded, sham-controlled trial of pneumatic compression in 35 adults. Symptom severity fell by 40 per cent on the IRLS scale, from 14.1 to 8.4 (p=0.006), and roughly one third reported complete relief while nobody on the sham device did.
On targeted foot compression, the open-label result is striking but limited. Kuhn et al. (2016), in the Journal of the American Osteopathic Association, followed 30 adults using targeted foot compression over eight weeks. Participants recorded a 90 per cent improvement on the Clinical Global Impression scale, against the 63 per cent published for ropinirole.
That gap needs its caveat stated plainly. The study had no control group, so the drug figure came from earlier separate trials and the two cannot be compared directly.
What Stillr is, and isn’t
Going to bed without negotiating with a tablet is the whole point, and that is what Stillr is: a drug-free compression sleeve worn overnight on both legs, no batteries, nothing to swallow. It is a wellness product, not a medicine, not a cure, and no substitute for your GP. Stillr is pre-launch, a flat AUD $169 a pair with free tracked shipping in Australia. Two sizes: Regular (AU women’s 5 to 8) and Large (AU women’s 8.5 to 11, men’s 7 to 10). Every pair carries a 60-Night Sleep Trial, with a full refund if your sleep does not improve.
You should not have to choose between a foggy morning and a restless night. Drug-free, on your own terms. You can reserve your pair and join the founders’ list at stillr.com.au.